Company
Guernsey
£755.0 Million
GBP as of July 1, 2024
US$955.1 Million
| Company | Market Cap (USD) |
|---|---|
| Blackstone | $148.37 B |
| BlackRock | $117.48 B |
| KKR & Co. Inc. | $97.78 B |
| Brookfield Corporation | $65.40 B |
| The Bank of New York Mellon Corporation | $44.78 B |
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $887.16 B |
| JPMorgan | $599.29 B |
| Visa | $550.38 B |
| Mastercard | $416.63 B |
| Bank of America | $316.02 B |
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Syncona Limited has the following listings and related stock indices.
Stock: LSE: SYNC wb_incandescent